ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CD38 Monoclonal Antibodies Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-0E6162
Home | Market Reports | Health| Health Conditions| Cancer
Global CD38 Monoclonal Antibodies Market Insights Forecast to 2028
BUY CHAPTERS

Global CD38 Monoclonal Antibodies Market Research Report 2025

Code: QYRE-Auto-0E6162
Report
June 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Sanofi
Janssen Biotech
Carbosynth
Creative-Biolabs
Boc Sciences

CD38 Monoclonal Antibodies Market

The global market for CD38 Monoclonal Antibodies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CD38 monoclonal antibodies target the CD38 surface antigen(sAg) of hematopoietic cells, which is important for cell function. Once CD38 monoclonal antibodies bind to the antigen it inhibits tumour growth by interrupting CD38 functions and causes cell death. CD38 monoclonal antibodies are used to treat multiple myeloma.
North American market for CD38 Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CD38 Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of CD38 Monoclonal Antibodies include Johnson & Johnson, Sanofi, Janssen Biotech, Carbosynth, Creative Biolabs, BOC Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for CD38 Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD38 Monoclonal Antibodies.
The CD38 Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of sales volume (Liter) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD38 Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD38 Monoclonal Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of CD38 Monoclonal Antibodies Market Report

Report Metric Details
Report Name CD38 Monoclonal Antibodies Market
Segment by Type
  • Daratumumab
  • Isatuximab
Segment by Application
  • Pharmacy
  • Laboratory Use
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, Sanofi, Janssen Biotech, Carbosynth, Creative Biolabs, BOC Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of CD38 Monoclonal Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of CD38 Monoclonal Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the CD38 Monoclonal Antibodies Market report?

Ans: The main players in the CD38 Monoclonal Antibodies Market are Johnson & Johnson, Sanofi, Janssen Biotech, Carbosynth, Creative Biolabs, BOC Sciences

What are the Application segmentation covered in the CD38 Monoclonal Antibodies Market report?

Ans: The Applications covered in the CD38 Monoclonal Antibodies Market report are Pharmacy, Laboratory Use

What are the Type segmentation covered in the CD38 Monoclonal Antibodies Market report?

Ans: The Types covered in the CD38 Monoclonal Antibodies Market report are Daratumumab, Isatuximab

1 CD38 Monoclonal Antibodies Market Overview
1.1 Product Definition
1.2 CD38 Monoclonal Antibodies by Type
1.2.1 Global CD38 Monoclonal Antibodies Market Value Comparison by Type (2024 VS 2031)
1.2.2 Daratumumab
1.2.3 Isatuximab
1.3 CD38 Monoclonal Antibodies by Application
1.3.1 Global CD38 Monoclonal Antibodies Market Value by Application (2024 VS 2031)
1.3.2 Pharmacy
1.3.3 Laboratory Use
1.4 Global CD38 Monoclonal Antibodies Market Size Estimates and Forecasts
1.4.1 Global CD38 Monoclonal Antibodies Revenue 2020-2031
1.4.2 Global CD38 Monoclonal Antibodies Sales 2020-2031
1.4.3 Global CD38 Monoclonal Antibodies Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 CD38 Monoclonal Antibodies Market Competition by Manufacturers
2.1 Global CD38 Monoclonal Antibodies Sales Market Share by Manufacturers (2020-2025)
2.2 Global CD38 Monoclonal Antibodies Revenue Market Share by Manufacturers (2020-2025)
2.3 Global CD38 Monoclonal Antibodies Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of CD38 Monoclonal Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CD38 Monoclonal Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD38 Monoclonal Antibodies, Product Type & Application
2.7 Global Key Manufacturers of CD38 Monoclonal Antibodies, Date of Enter into This Industry
2.8 Global CD38 Monoclonal Antibodies Market Competitive Situation and Trends
2.8.1 Global CD38 Monoclonal Antibodies Market Concentration Rate
2.8.2 The Global 5 and 10 Largest CD38 Monoclonal Antibodies Players Market Share by Revenue
2.8.3 Global CD38 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global CD38 Monoclonal Antibodies Market Scenario by Region
3.1 Global CD38 Monoclonal Antibodies Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global CD38 Monoclonal Antibodies Sales by Region: 2020-2031
3.2.1 Global CD38 Monoclonal Antibodies Sales by Region: 2020-2025
3.2.2 Global CD38 Monoclonal Antibodies Sales by Region: 2026-2031
3.3 Global CD38 Monoclonal Antibodies Revenue by Region: 2020-2031
3.3.1 Global CD38 Monoclonal Antibodies Revenue by Region: 2020-2025
3.3.2 Global CD38 Monoclonal Antibodies Revenue by Region: 2026-2031
3.4 North America CD38 Monoclonal Antibodies Market Facts & Figures by Country
3.4.1 North America CD38 Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America CD38 Monoclonal Antibodies Sales by Country (2020-2031)
3.4.3 North America CD38 Monoclonal Antibodies Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe CD38 Monoclonal Antibodies Market Facts & Figures by Country
3.5.1 Europe CD38 Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe CD38 Monoclonal Antibodies Sales by Country (2020-2031)
3.5.3 Europe CD38 Monoclonal Antibodies Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD38 Monoclonal Antibodies Market Facts & Figures by Region
3.6.1 Asia Pacific CD38 Monoclonal Antibodies Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific CD38 Monoclonal Antibodies Sales by Region (2020-2031)
3.6.3 Asia Pacific CD38 Monoclonal Antibodies Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America CD38 Monoclonal Antibodies Market Facts & Figures by Country
3.7.1 Latin America CD38 Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America CD38 Monoclonal Antibodies Sales by Country (2020-2031)
3.7.3 Latin America CD38 Monoclonal Antibodies Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD38 Monoclonal Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa CD38 Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa CD38 Monoclonal Antibodies Sales by Country (2020-2031)
3.8.3 Middle East and Africa CD38 Monoclonal Antibodies Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD38 Monoclonal Antibodies Sales by Type (2020-2031)
4.1.1 Global CD38 Monoclonal Antibodies Sales by Type (2020-2025)
4.1.2 Global CD38 Monoclonal Antibodies Sales by Type (2026-2031)
4.1.3 Global CD38 Monoclonal Antibodies Sales Market Share by Type (2020-2031)
4.2 Global CD38 Monoclonal Antibodies Revenue by Type (2020-2031)
4.2.1 Global CD38 Monoclonal Antibodies Revenue by Type (2020-2025)
4.2.2 Global CD38 Monoclonal Antibodies Revenue by Type (2026-2031)
4.2.3 Global CD38 Monoclonal Antibodies Revenue Market Share by Type (2020-2031)
4.3 Global CD38 Monoclonal Antibodies Price by Type (2020-2031)
5 Segment by Application
5.1 Global CD38 Monoclonal Antibodies Sales by Application (2020-2031)
5.1.1 Global CD38 Monoclonal Antibodies Sales by Application (2020-2025)
5.1.2 Global CD38 Monoclonal Antibodies Sales by Application (2026-2031)
5.1.3 Global CD38 Monoclonal Antibodies Sales Market Share by Application (2020-2031)
5.2 Global CD38 Monoclonal Antibodies Revenue by Application (2020-2031)
5.2.1 Global CD38 Monoclonal Antibodies Revenue by Application (2020-2025)
5.2.2 Global CD38 Monoclonal Antibodies Revenue by Application (2026-2031)
5.2.3 Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2020-2031)
5.3 Global CD38 Monoclonal Antibodies Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson CD38 Monoclonal Antibodies Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi CD38 Monoclonal Antibodies Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Janssen Biotech
6.3.1 Janssen Biotech Company Information
6.3.2 Janssen Biotech Description and Business Overview
6.3.3 Janssen Biotech CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Janssen Biotech CD38 Monoclonal Antibodies Product Portfolio
6.3.5 Janssen Biotech Recent Developments/Updates
6.4 Carbosynth
6.4.1 Carbosynth Company Information
6.4.2 Carbosynth Description and Business Overview
6.4.3 Carbosynth CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Carbosynth CD38 Monoclonal Antibodies Product Portfolio
6.4.5 Carbosynth Recent Developments/Updates
6.5 Creative Biolabs
6.5.1 Creative Biolabs Company Information
6.5.2 Creative Biolabs Description and Business Overview
6.5.3 Creative Biolabs CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Creative Biolabs CD38 Monoclonal Antibodies Product Portfolio
6.5.5 Creative Biolabs Recent Developments/Updates
6.6 BOC Sciences
6.6.1 BOC Sciences Company Information
6.6.2 BOC Sciences Description and Business Overview
6.6.3 BOC Sciences CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BOC Sciences CD38 Monoclonal Antibodies Product Portfolio
6.6.5 BOC Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD38 Monoclonal Antibodies Industry Chain Analysis
7.2 CD38 Monoclonal Antibodies Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD38 Monoclonal Antibodies Production Mode & Process Analysis
7.4 CD38 Monoclonal Antibodies Sales and Marketing
7.4.1 CD38 Monoclonal Antibodies Sales Channels
7.4.2 CD38 Monoclonal Antibodies Distributors
7.5 CD38 Monoclonal Antibodies Customer Analysis
8 CD38 Monoclonal Antibodies Market Dynamics
8.1 CD38 Monoclonal Antibodies Industry Trends
8.2 CD38 Monoclonal Antibodies Market Drivers
8.3 CD38 Monoclonal Antibodies Market Challenges
8.4 CD38 Monoclonal Antibodies Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Sanofi
Janssen Biotech
Carbosynth
Creative-Biolabs
Boc Sciences
List of Tables
 Table 1. Global CD38 Monoclonal Antibodies Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global CD38 Monoclonal Antibodies Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global CD38 Monoclonal Antibodies Market Competitive Situation by Manufacturers in 2024
 Table 4. Global CD38 Monoclonal Antibodies Sales (Liter) of Key Manufacturers (2020-2025)
 Table 5. Global CD38 Monoclonal Antibodies Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global CD38 Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global CD38 Monoclonal Antibodies Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market CD38 Monoclonal Antibodies Average Price (US$/ml) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of CD38 Monoclonal Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of CD38 Monoclonal Antibodies, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of CD38 Monoclonal Antibodies, Product Type & Application
 Table 12. Global Key Manufacturers of CD38 Monoclonal Antibodies, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global CD38 Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD38 Monoclonal Antibodies as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global CD38 Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global CD38 Monoclonal Antibodies Sales by Region (2020-2025) & (Liter)
 Table 18. Global CD38 Monoclonal Antibodies Sales Market Share by Region (2020-2025)
 Table 19. Global CD38 Monoclonal Antibodies Sales by Region (2026-2031) & (Liter)
 Table 20. Global CD38 Monoclonal Antibodies Sales Market Share by Region (2026-2031)
 Table 21. Global CD38 Monoclonal Antibodies Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global CD38 Monoclonal Antibodies Revenue Market Share by Region (2020-2025)
 Table 23. Global CD38 Monoclonal Antibodies Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global CD38 Monoclonal Antibodies Revenue Market Share by Region (2026-2031)
 Table 25. North America CD38 Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America CD38 Monoclonal Antibodies Sales by Country (2020-2025) & (Liter)
 Table 27. North America CD38 Monoclonal Antibodies Sales by Country (2026-2031) & (Liter)
 Table 28. North America CD38 Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America CD38 Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe CD38 Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe CD38 Monoclonal Antibodies Sales by Country (2020-2025) & (Liter)
 Table 32. Europe CD38 Monoclonal Antibodies Sales by Country (2026-2031) & (Liter)
 Table 33. Europe CD38 Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe CD38 Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific CD38 Monoclonal Antibodies Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific CD38 Monoclonal Antibodies Sales by Region (2020-2025) & (Liter)
 Table 37. Asia Pacific CD38 Monoclonal Antibodies Sales by Region (2026-2031) & (Liter)
 Table 38. Asia Pacific CD38 Monoclonal Antibodies Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific CD38 Monoclonal Antibodies Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America CD38 Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America CD38 Monoclonal Antibodies Sales by Country (2020-2025) & (Liter)
 Table 42. Latin America CD38 Monoclonal Antibodies Sales by Country (2026-2031) & (Liter)
 Table 43. Latin America CD38 Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America CD38 Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa CD38 Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa CD38 Monoclonal Antibodies Sales by Country (2020-2025) & (Liter)
 Table 47. Middle East and Africa CD38 Monoclonal Antibodies Sales by Country (2026-2031) & (Liter)
 Table 48. Middle East and Africa CD38 Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa CD38 Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global CD38 Monoclonal Antibodies Sales (Liter) by Type (2020-2025)
 Table 51. Global CD38 Monoclonal Antibodies Sales (Liter) by Type (2026-2031)
 Table 52. Global CD38 Monoclonal Antibodies Sales Market Share by Type (2020-2025)
 Table 53. Global CD38 Monoclonal Antibodies Sales Market Share by Type (2026-2031)
 Table 54. Global CD38 Monoclonal Antibodies Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global CD38 Monoclonal Antibodies Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global CD38 Monoclonal Antibodies Revenue Market Share by Type (2020-2025)
 Table 57. Global CD38 Monoclonal Antibodies Revenue Market Share by Type (2026-2031)
 Table 58. Global CD38 Monoclonal Antibodies Price (US$/ml) by Type (2020-2025)
 Table 59. Global CD38 Monoclonal Antibodies Price (US$/ml) by Type (2026-2031)
 Table 60. Global CD38 Monoclonal Antibodies Sales (Liter) by Application (2020-2025)
 Table 61. Global CD38 Monoclonal Antibodies Sales (Liter) by Application (2026-2031)
 Table 62. Global CD38 Monoclonal Antibodies Sales Market Share by Application (2020-2025)
 Table 63. Global CD38 Monoclonal Antibodies Sales Market Share by Application (2026-2031)
 Table 64. Global CD38 Monoclonal Antibodies Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global CD38 Monoclonal Antibodies Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2020-2025)
 Table 67. Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2026-2031)
 Table 68. Global CD38 Monoclonal Antibodies Price (US$/ml) by Application (2020-2025)
 Table 69. Global CD38 Monoclonal Antibodies Price (US$/ml) by Application (2026-2031)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 73. Johnson & Johnson CD38 Monoclonal Antibodies Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 78. Sanofi CD38 Monoclonal Antibodies Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Janssen Biotech Company Information
 Table 81. Janssen Biotech Description and Business Overview
 Table 82. Janssen Biotech CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 83. Janssen Biotech CD38 Monoclonal Antibodies Product
 Table 84. Janssen Biotech Recent Developments/Updates
 Table 85. Carbosynth Company Information
 Table 86. Carbosynth Description and Business Overview
 Table 87. Carbosynth CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 88. Carbosynth CD38 Monoclonal Antibodies Product
 Table 89. Carbosynth Recent Developments/Updates
 Table 90. Creative Biolabs Company Information
 Table 91. Creative Biolabs Description and Business Overview
 Table 92. Creative Biolabs CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 93. Creative Biolabs CD38 Monoclonal Antibodies Product
 Table 94. Creative Biolabs Recent Developments/Updates
 Table 95. BOC Sciences Company Information
 Table 96. BOC Sciences Description and Business Overview
 Table 97. BOC Sciences CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 98. BOC Sciences CD38 Monoclonal Antibodies Product
 Table 99. BOC Sciences Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. CD38 Monoclonal Antibodies Distributors List
 Table 103. CD38 Monoclonal Antibodies Customers List
 Table 104. CD38 Monoclonal Antibodies Market Trends
 Table 105. CD38 Monoclonal Antibodies Market Drivers
 Table 106. CD38 Monoclonal Antibodies Market Challenges
 Table 107. CD38 Monoclonal Antibodies Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of CD38 Monoclonal Antibodies
 Figure 2. Global CD38 Monoclonal Antibodies Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global CD38 Monoclonal Antibodies Market Share by Type: 2024 & 2031
 Figure 4. Daratumumab Product Picture
 Figure 5. Isatuximab Product Picture
 Figure 6. Global CD38 Monoclonal Antibodies Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global CD38 Monoclonal Antibodies Market Share by Application: 2024 & 2031
 Figure 8. Pharmacy
 Figure 9. Laboratory Use
 Figure 10. Global CD38 Monoclonal Antibodies Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global CD38 Monoclonal Antibodies Market Size (2020-2031) & (US$ Million)
 Figure 12. Global CD38 Monoclonal Antibodies Sales (2020-2031) & (Liter)
 Figure 13. Global CD38 Monoclonal Antibodies Average Price (US$/ml) & (2020-2031)
 Figure 14. CD38 Monoclonal Antibodies Report Years Considered
 Figure 15. CD38 Monoclonal Antibodies Sales Share by Manufacturers in 2024
 Figure 16. Global CD38 Monoclonal Antibodies Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest CD38 Monoclonal Antibodies Players: Market Share by Revenue in CD38 Monoclonal Antibodies in 2024
 Figure 18. CD38 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global CD38 Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America CD38 Monoclonal Antibodies Sales Market Share by Country (2020-2031)
 Figure 21. North America CD38 Monoclonal Antibodies Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe CD38 Monoclonal Antibodies Sales Market Share by Country (2020-2031)
 Figure 25. Europe CD38 Monoclonal Antibodies Revenue Market Share by Country (2020-2031)
 Figure 26. Germany CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific CD38 Monoclonal Antibodies Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific CD38 Monoclonal Antibodies Revenue Market Share by Region (2020-2031)
 Figure 33. China CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America CD38 Monoclonal Antibodies Sales Market Share by Country (2020-2031)
 Figure 44. Latin America CD38 Monoclonal Antibodies Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa CD38 Monoclonal Antibodies Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa CD38 Monoclonal Antibodies Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE CD38 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of CD38 Monoclonal Antibodies by Type (2020-2031)
 Figure 54. Global Revenue Market Share of CD38 Monoclonal Antibodies by Type (2020-2031)
 Figure 55. Global CD38 Monoclonal Antibodies Price (US$/ml) by Type (2020-2031)
 Figure 56. Global Sales Market Share of CD38 Monoclonal Antibodies by Application (2020-2031)
 Figure 57. Global Revenue Market Share of CD38 Monoclonal Antibodies by Application (2020-2031)
 Figure 58. Global CD38 Monoclonal Antibodies Price (US$/ml) by Application (2020-2031)
 Figure 59. CD38 Monoclonal Antibodies Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global Anti CD20 Monoclonal Antibodies Market Research Report 2024
CD38 Monoclonal Antibody Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Monoclonal Antibody for Gastric Cancer Market Research Report 2024
Global Anti CD25 Monoclonal Antibody Market Research Report 2024
Global Monoclonal Antibodies for Alzheimer Disease Market Research Report 2024
Global Hepatocellular Carcinoma Monoclonal Antibody Market Research Report 2025
Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030
Global Monoclonal Antibodies for Non small Cell Lung Cancer Market Research Report 2025
Global Granulocytes Monoclonal Antibody Market Research Report 2024
Global Anti p38 MAPKs Antibody Market Research Report 2024
Global Conjugated Monoclonal Antibodies Market Research Report 2024
Global Monoclonal Antibody for Multiple Myeloma Market Research Report 2024
Global Aβ Monoclonal Antibody Drug Market Research Report 2024
Global Anti α4β7 Integrin Monoclonal Antibody Market Research Report 2024
Global CD Antigen Cancer Therapy Market Research Report 2025
Global Monoclonal Antibody VEGF Inhibitors Market Research Report 2024
Global Erythrocytes Monoclonal Antibody Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions